Tags:
Journalism of Courage
Sun Pharmaceutical Industries will stop selling generic version of Sanofi-Aventis8217; cancer drug Eloxatin in the United States after June 30 following a court order,the drugmaker said.
In April,Sanofi-Aventis settled a patent law suit over Eloxatin with additional drugmakers,stopping them from selling their generic versions in the United States from June 30 until August 2012.
Caraco Pharmaceutical Laboratories,a unit of Sun Pharmaceutical,had said in March it had launched the generic version of anti-cancer drug oxaliplatin in injection form in the United States.
